Disclosures None.

Slides:



Advertisements
Similar presentations
LQTS Outline Background Identification Therapies Available
Advertisements

Lab/ECG/Xray Rounds The EM Resident Provisionally Known as Sean Caine CCFP-EM March 5, 2008.
Syncope in Children.
Brugada’s Syndrome and Sudden Cardiac Death
Cardiac Arrhythmia in Thalassaemia Limassol, 24 – 26 October 2012 Malcolm Walker University College and the Heart Hospitals, London Clinical Director Hatter.
Cardiovascular Disaster in Hemodialysis patients
April 1 st, 2013 Heart Failure Education Series David N. Edwards, M.D. Ph.D. F.A.C.C. Advanced Heart Care, PA The Heart Hospital Baylor Plano.
Valsartan Antihypertensive Long-Term Use Evaluation Results
©2014 MFMER | slide-1 Cardiac Screening in Athletes A Brief Review Sara Filmalter, MD Mayo Clinic Florida Jacksonville Sports Medicine Symposium April.
Hypertrophic Cardiomyopathy Guidelines Summary from the: ACC/ESC Clinical Expert Consensus Statement on Hypertrophic Cardiomyopathy Maron BJ, et al. J.
Implantable Cardioverter Defibrillators to Prevent Sudden Cardiac Death: Background Frederick A. Masoudi, MD, MSPH Associate Professor of Medicine (Cardiology)
: Epidemiology of Morbidity and Mortality from Particles and Co-Pollutants: Respiratory, Cardiovascular, and Cancer Douglas W. Dockery Harvard School of.
Cardiac Issues in Friedreich’s Ataxia 2 nd Annual Friedreich’s Ataxia Symposium Robert E. Shaddy, MD Jennifer Terker Professor of Pediatrics Division Chief,
Heart disease. Congenital Ischemic Hypertensive Valvular Cardiomyopathy Pericardium Tumors.
Cardiac Arrhythmias in Coronary Heart Disease SIGN 94.
Device-Based Therapy of Cardiac Rhythm Abnormalities
Atrial Fibrillation Andreas Stein Robert Smith, M.D. August 11, 2003.
Septal ablation in Hypertrophic Cardiomyopathy Charles Knight London Chest Hospital Advanced Angioplasty 2003.
Devices and the older patient with syncope Michael Gammage, Reader in Cardiovascular Medicine MHRA Committee for Safety of Devices.
Syncope diagnostic algorithm and management MUDr. Jakub Honěk Kardiologická klinika, 2.LF UK a FN Motol, Praha.
Lancet 373: , 2009 Baseline Characteristics of Participants and Study Design of Clinical Trials to Compare Intensive glucose- lowering versus.
William M. Miles, MD, FHRS University of Florida College of Medicine Gainesville, FL ICD Implantation: Genetic Arrhythmia Syndromes.
Ordering Echocardiograms for Syncope Cost Conscious Project Marvin Chang, PGY2.
 Understand the term syncope.  Differentiate the serious causes of syncope from those that are benign.  Know the appropriate testing needed in the.
Cardiovascular Module
ECHOs in Syncope Cost Consciousness Project Aceela Muqri, PGY-2.
Introduction BACKGROUND  N on-sustained VT (NSVT) is a known risk factor for poor outcomes in adults with HCM and diastolic dysfunction is linked to poor.
Charmaine J. Palafox, MD. Approx. 50% of CHD deaths occurs as sudden cardiac arrest.
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Omega-3 Polyunsaturated Fatty Acids and Cardiovascular.
Unnecessary Lipid Screening of Inpatient Admissions Dennis Whang 4/2/12 DSR2.
Consultant Cardiologist
THE HEART’S ELECTRICAL SYSTEM Marco Perez, MD Center for Inherited Cardiovascular Disease Inherited Cardiac Arrhythmia Clinic June 20, 2013.
Recurrent Syncope in Childhood 26/11/15. What is Syncope? Syncope is a temporary loss of consciousness resulting from a reversible disturbance of cerebral.
Emergency Medicine Junior Teaching Programme Aberdeen Royal Infirmary Adult Syncope Evaluation in the Emergency Department Jamie Cooper Teaching 4 th March.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Scope of Coronary Heart Disease in Patients With.
Date of download: 7/6/2016 Copyright © The American College of Cardiology. All rights reserved. From: Hypertrophic Cardiomyopathy in Adulthood Associated.
“I Need This Form Filled Out”: Pediatric Sports Physical Assessment Aaron T Dorfman, MD Pediatric Cardiology New Jersey Section The Children’s Hospital.
Sudden Cardiac Arrest Morhaf Ibrahim, MD, FHRS Electrophysiology.
Hypertension in the Post SPRINT era
Dr. Wong Oi Fung Journal Club Presentation ICU TMH
In certain patients with the long QT syndrome, potassium channel function is reduced (diagonal arrows), which leads to prolongation of the action potential.
LEADER trial: Primary Outcome
Clinical need for determination of vulnerable plaques
Brugada’s Syndrome and Sudden Cardiac Death
Cardiac Arrhythmias in Acute Myocardial Infarction II
Cardiac Screening in Athletes A Brief Review
Echocardiograms in syncope work-up
Objectives Understand the term syncope.
TNT: Baseline and final LDL cholesterol levels
Arrhythmogenic right ventricular dysplasia
The EP show: sudden death, part 1 Director
Syncope in children.
Joerg Herrmann, MD, Amir Lerman, MD, Nicole P
Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease  Sripal Bangalore, MD, MHA, Rana Fayyad, PhD,
Demographics and Epidemiology of Sudden Deaths in Young Competitive Athletes: From the United States National Registry  Barry J. Maron, MD, Tammy S. Haas,
The Hypertension in the Very Elderly Trial (HYVET)
Volume 13, Issue 1, Pages (January 2016)
Volume 15, Issue 10, Pages e73-e189 (October 2018)
Interventional cardiologist & internist
Volume 15, Issue 1, Pages (January 2018)
Significance of Periprocedural Myocardial Infarctions in Percutaneous Coronary Interventions A New Look at an Old Topic Abhiram Prasad, MD, FRCP, FESC,
Potential mechanisms whereby statins may reduce the risk of stroke
Syncope diagnostic algorithm and management
Slides courtesy of Dr. Randall Harada
Diagnosis at presentation and diagnoses finally reached at the end of the inpatient admission. Diagnosis at presentation and diagnoses finally reached.
Jeffrey B. Geske et al. JCHF 2018;j.jchf
Diabetes, prediabetes, and cardiovascular risk: Shifting the paradigm
Cumulative incidence of cardiovascular events according to medication group in participants of the 4D study with an LDL-C in its fourth quartile at baseline.
EMPA-REG OUTCOME: Cumulative incidence of the primary outcome
Traditional cardiovascular risk factors can cause cardiac disease in patients with IIM. Systemic and local inflammation may either have a direct effect.
Presentation transcript:

Disclosures None

Ventricular Arrhythmias When do I need to worry? Fred Kusumoto MD Professor of Medicine Mayo Clinic College of Medicine Kusumoto.Fred@mayo.edu 18th Annual Primary Care and Cardiovascular Symposium Jacksonville Fl – May 19, 2017

Ventricular Arrhythmias: When do I need to worry? How scary? Structural Heart Disease? Funny Genetic Disorder? Symptoms?

Ventricular Arrhythmias: When do I need to worry? How scary? Structural Heart Disease? Funny Genetic Disorder? Symptoms?

Number of consecutive beats: “Sustained >>> Nonsustained > PVCs” Kusumoto, ECG Interpretation: from Pathophysiology to Clinical Application 2009

Rate: “Slow = Less scary” Kusumoto, ECG Interpretation: from Pathophysiology to Clinical Application 2009

Coupling Interval: “Shorter = scarier” (“R on T”)

Coupling interval “Longer = less scarier”

Ventricular Arrhythmias: When do I need to worry? How scary? How many in a row? Rate Coupling Structural Heart Disease? Funny Genetic Disorder? Symptoms?

Ventricular Arrhythmias: When do I need to worry? How scary? How many in a row? Rate Coupling Structural Heart Disease? Funny Genetic Disorder? Symptoms?

Abnormal LV: Hypertrophic cardiomyopathy Kusumoto FM. ECG Interpretation: From Pathophysiology to Clinical Application 2009

Bernath and Kusumoto. ECG Interpretation for Everyone 2011

Normal ventricular activation Precordial morphology

Normal ventricular activation Precordial morphology

Abnormal LV: Hypertrophic cardiomyopathy Kusumoto FM. ECG Interpretation: From Pathophysiology to Clinical Application 2009

Abnormal LV: Myocardial Infarction Kusumoto FM. ECG Interpretation: From Pathophysiology to Clinical Application 2009

Abnormal RV: Congenital heart disease? Kusumoto FM. ECG Interpretation: From Pathophysiology to Clinical Application 2009

Ventricular Arrhythmias: When do I need to worry? How scary? Structural Heart Disease? LV: LVEF, HCM RV: Congenital heart disease Funny Genetic Disorder? Symptoms?

Ventricular Arrhythmias: When do I need to worry? How scary? Structural Heart Disease? LV: LVEF, HCM RV: Congenital heart disease Funny Genetic Disorder? Symptoms?

Commonest funny genetic “channelopathies” Brugada Syndrome Na+

Commonest funny genetic “channelopathies” Brugada Syndrome Na+

ECG: Brugada Syndrome Kusumoto FM, ECG Interpretation: From Physiology to Practical Application 2009

Ventricular action potential

Ventricular action potential

Ventricular action potential

Commonest funny genetic “channelopathies” Brugada Syndrome Long QT Syndrome Na+ K+

Commonest funny genetic “channelopathies” Brugada Syndrome Long QT Syndrome Na+ K+

Ventricular action potential

Ventricular action potential EAD Action potential lengthening can lead to early reactivation of the cells (EADs)

Ventricular action potential EAD Action potential lengthening can lead to early reactivation of the cells (EADs)

Anna Nicole Smith Kusumoto FM, ECG Interpretation: From Physiology to Practical Application 2009

Long QT Syndrome: Assessing risk Kusumoto FM, ECG Interpretation: From Physiology to Practical Application 2009 Schwartz Circ 2010

Ventricular Arrhythmias: When do I need to worry? How scary? Structural Heart Disease? Funny Genetic Disorder? Long QT Brugada Syndrome Symptoms?

Ventricular Arrhythmias: When do I need to worry? How scary? Structural Heart Disease? Funny Genetic Disorder? Long QT Brugada Syndrome Symptoms?

Probability of Survival Prognosis of Syncope: Framingham 5 10 15 20 25 0.0 0.2 0.4 0.6 0.8 1.0 Follow-up (yr) Probability of Survival No syncope Vasovagal and other causes Unknown cause Neurologic cause Cardiac cause Figure 2. Overall Survival of Participants with Syncope, According to Cause, and Participants without Syncope. P<0.001 for the comparison between participants with and those without syncope. The category “Vasovagal and other causes” includes vasovagal, orthostatic, medication-induced, and other, infrequent causes of syncope. The only difference between syncope and sudden cardiac death is that in syncope, you wake up. Anonymous Recently, the Framingham Heart Study provided an update regarding the incidence, specific causes, and prognosis of transient loss of consciousness episodes. Of 7814 study participants followed for an average of 17 years, 822 reported ‘syncope’. The incidence of a first report of syncope was 6.2 per 1000 person-years. The most frequently identified causes were vasovagal (21%), cardiac (9.5%), and orthostatic (9.4%); for 37% the cause was unknown. The participants with syncope from any cause, as compared with those who did not have syncope, had 1.31 increased risk for death from any cause, 1.27 for myocardial infarction or death from coronary heart disease, and 1.06 for fatal or nonfatal stroke. Persons with cardiac syncope were at increased risk for death from any cause (hazard ratio of 2.1) and cardiovascular events (hazard ratio of 2.66), and persons with syncope of unknown cause and neurologic syncope were at increased risk for death of 1.32 and 1.54 respectively. There was no increased risk of cardiovascular morbidity or mortality associated with vasovagal (including orthostatic and medication-related) syncope. Patients with cardiac causes for syncope have a significantly increased mortality risk. Over 30% of adults will have an episode of syncope during their lifetime. Framingham Soteriades ES, Evans JC, Larson MG, et al. NEJM. 2002;347:878-85.

Etiology of Syncope and Age Parry et al, BMJ 2010

Identifying cardiac syncope based on clinical history Berecki Gisolf et al PLOS 2013

Ventricular Arrhythmia Algorithm What did the ventricular arrhythmia look like? Rhythm strip, ECG History ECG Echocardiography (MRI) Does the patient have structural heart disease? Does the patient have something funny? Family History ECG Symptoms? History

Ventricular Arrhythmias: When do I need to worry? How scary? Structural Heart Disease? Funny Genetic Disorder? Symptoms? History Exam ECG Echo